Compare Nuwellis Inc (NUWE) vs iShares Semiconductor ETF (SOXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs iShares Semiconductor ETF — how do they compare? Nuwellis Inc trades at $0.7 (market cap $2.20M), while iShares Semiconductor ETF trades at $559.78 (market cap $48.19B). The key difference: iShares Semiconductor ETF is far larger — about 21904.5× Nuwellis Inc's market cap, and iShares Semiconductor ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and iShares Semiconductor ETF for 46 Days on average.
| NUWE | SOXX | |
|---|---|---|
Market Cap | $2.20M | $48.19B |
Volume | 121,544 | 10,257,578 |
Sector | Health | Sector/Thematic |
52-Week High | $146.65 | $655.01 |
52-Week Low | $0.68 | $268.10 |
Typical Hold Time | 26 Days | 46 Days |
Enterprise Value | -$1.52M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
SOXX trades at $559.40, down 4.04% over the past 24 hours, with technical indicators showing a bullish moving average signal but neutral oscillators. The semiconductor ETF faces mixed sentiment with strong AI-driven earnings growth projections but concerns about valuation premiums. Recent corporate actions include a 1:3 stock split scheduled for November 2026 and a $0.33 dividend payment in September 2026.
The outlook remains cautiously optimistic with AI infrastructure demand driving earnings growth, though high valuations and bearish bets from notable investors like Michael Burry present significant risks. Wall Street analysts maintain positive ratings based on semiconductor market expansion projections, with Bank of America forecasting near-doubling of the global chip market by 2030.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About iShares Semiconductor ETF
SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Read more on SOXX →
